Annovis Bio, Inc. (ANVS) › Total AssetsAnnovis Bio, Inc. (ANVS) — Total AssetsAnnual figures by period end, from SEC filings.2019-12-31: $1.12M2020-12-31: $8.12M2021-12-31: $46.00M2022-03-31: $44.10M2022-06-30: $39.97M2022-09-30: $37.12M2022-12-31: $36.02M2023-12-31: $10.21M2024-12-31: $13.93M2025-12-31: $21.08M$21.08M2019-12-31Total Assets (USD)2025-12-31Period endedTotal AssetsChange YoYSource filing2025-12-31$21.08M+51.4%2026-03-13Balance as of period end2024-12-31$13.93M+36.4%2026-03-13Balance as of period end2023-12-31$10.21M-71.7%2025-03-21Balance as of period end2022-12-31$36.02M—2024-03-29Balance as of period end2022-09-30$37.12M—2023-03-31Balance as of period end2022-06-30$39.97M—2023-03-31Balance as of period end2022-03-31$44.10M—2023-03-31Balance as of period end2021-12-31$46.00M+466.6%2023-03-31Balance as of period end2020-12-31$8.12M+626.8%2022-03-02Balance as of period end2019-12-31$1.12M—2021-03-03Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)